MED1 and cardiomyopathy: Since disturbances in PPARα and PPARδ regulated FAO has been implicated in cardiomyopathy, we inferred that Med1 deletion in cardiomyocytes perturbs myocardial FAO and energy metabolism [32–36] in csMed1-/- hearts (Table 1, Fig 4).